Abstract
Sweet taste receptors are composed of a heterodimer of taste 1 receptor member 2 (T1R2) and taste 1 receptor member 3 (T1R3). Accumulating evidence shows that sweet taste receptors are ubiquitous throughout the body, including in the gastrointestinal tract as well as the hypothalamus. These sweet taste receptors are heavily involved in nutrient sensing, monitoring changes in energy stores, and triggering metabolic and behavioral responses to maintain energy balance. Not surprisingly, these pathways are heavily regulated by external and internal factors. Dysfunction in one or more of these pathways may be important in the pathogenesis of common diseases, such as obesity and type 2 diabetes mellitus.
Keywords: sweet taste receptors, glucose sensing, nutrient sensing, leptin, hypothalamus
1. Chemosensory Cells in the Tongue
Humans can distinguish between five basic tastes, including sweet, salty, umami, bitter, and sour. Recently, lipid sensors have been identified on the tongue which suggests that fat can be considered as the sixth taste [1]. Taste processing is first achieved at the level of taste receptor cells (TRCs) which are clustered in taste buds on the tongue. When TRCs are activated by specific tastants, they transmit information via sensory afferent fibers to specific areas in the brain that are involved in taste perception. Four morphologic subtypes of TRCs have been identified. Type I glial-like cells detect salty taste. Type II cells express G-protein coupled receptors (GPCRs) to detect sweet, umami, and bitter tastes. Type III cells sense sour stimuli, while Type IV cells likely represent stem or progenitor taste cells [2]. Type II cells do not form traditional synapses with afferent nerve fibers. Rather, these cells release ATP through hemichannels, which can then activate purinergic receptors (P2N2 and P2X3) present on the cranial nerve fibers innervating each taste bud (Figure 1) [3,4,5].
Two classes of GPCRs have been identified, including taste 1 receptor family (T1R) and the taste 2 receptor family (T2R) [6]. Two subtypes of the T1R family, including T1R member 2 (T1R2) and T1R member 3 (T1R3), form heterodimers to act as sweet taste receptors [7,8].
2. Sweet Taste Signaling
Sweet taste receptors can be activated by a wide range of chemically different compounds, including sugars (glucose, fructose, sucrose, maltose), artificial sweeteners (e.g., saccharin, aspartame, cyclamate), sweet amino acids (d-tryptophan, d-phenylalanine, d-serine), and sweet proteins (monellin, brazzein, thaumatin) [9]. Binding of a ligand to the sweet taste receptor leads to activation of the heterotrimeric G-protein α-gustducin. Phospholipase C β2 is subsequently stimulated, leading to release of intracellular Ca2+ and activation of the transient receptor potential cation channel M5 (TRPM5). This sequence results in the release of ATP, which can then activate adjacent sensory afferent neurons that send signals to brain centers involved in taste perception (Figure 2) [10].
Taste cells also express bioactive peptides, including glucagon-like peptide-1 (GLP-1), glucagon, neuropeptide Y, peptide YY (PYY), cholecystokinin (CCK), vasoactive intestinal peptide, and ghrelin [11]. Although the function of these peptides in taste buds is still unknown, their presence suggests a role in the processing and modulation of taste information at the level of the taste bud.
3. Chemosensory Cells in the GI Tract
Although taste receptors were initially discovered in taste buds, a growing number of studies have demonstrated that sweet taste receptors are expressed throughout the body, including the nasal epithelium, respiratory system, pancreatic islet cells, and even in sperm and testes [12,13,14].
In the gut, sweet taste receptors are mainly concentrated on enteroendocrine cells. Although these cells represent a small proportion of the total number of epithelial cells in the gastrointestinal (GI) tract, collectively they form the largest endocrine organ in the body [15]. Over 20 different types of enteroendocrine cell types have been identified to date, each of which secretes one or more regulatory peptides or bioactive molecules (Table 1). These hormones can act locally on enteroendocrine cells, on immune cells, nerve endings, or organs at remote sites including pancreatic islets and the central nervous system (CNS). This results in changes in appetite and satiety, inhibition of gastric emptying, stimulation of gastric secretion, pancreatic exocrine and endocrine secretion, induction of nutrient transporters and digestive enzymes, an increase in intestinal barrier function, and modulation of immune responses and tissue growth [15,16,17,18,19].
Table 1.
Cell | Products | Luminal Receptors | Locations | Principal Effects |
---|---|---|---|---|
A (X-like) cells and subtypes | Ghrelin, nesfatin-1 | T1R1-T1R3; T2Rs | Stomach | Appetite control, growth hormone release |
Enterochromaffin cells *,‡ | 5-HT (5-HT is also contained in subgroups of I, K, and L cells) | FFARs 2, 3; TRPA1; toxin receptors; TLRs | Stomach, small and large intestine | Facilitation of intestinal motility reflexes and secretion; triggering of emesis and nausea in response to toxins |
I cells | CCK (5-HT) | T2Rs; FFA1; GPR120; LPAR5; CaSR; TRPA1; TLRs | Proximal small intestine | Activation of gallbladder contraction and stimulation of pancreatic enzyme secretion |
K cells, and subtypes | GIP | GPR119, GPR120; FFAR1 | Proximal small intestine | Stimulation of insulin release |
L cells, and subtypes ‡ | GLP-1, GLP-2, PYY, oxyntomodulin (5-HT) | T2Rs; T1R2–T1R3; FFARs 1–3; GPR119, LPAR5, GPR120; CaSR | Distal small intestine, colon | Stimulation of carbohydrate uptake, slowing of intestinal transit, appetite regulation, insulin release |
P cells | Leptin | Nutrient receptors | Stomach | Appetite regulation, reduction of food intake |
* ECL cells do not contact the lumen. ‡ Sweet taste receptor molecules have been identified within L cells and enterochromaffin (EC) cells. Abbreviations: T1R, taste 1 receptor family; T2R, taste 2 receptor family; 5-HT, serotonin; ECL, enterochromaffin-like; FFAR, free fatty acid receptor; TRP, transient receptor potential; TLR, Toll-like receptor; FFA, free fatty acid; FFARs, free fatty acid receptors; GPR, G protein-coupled receptor; LPAR, lysophosphatidic acid receptor; CaSR, calcium-sensing receptor; CCK, cholecystokinin; GIP, gastric inhibitory polypeptide; GLP, glucagon-like peptide; PYY, peptide YY.
The function of the sweet taste receptor system in the gastrointestinal tract is likely involved in nutrient sensing, glucose homeostasis, as well as secretion of GI peptides. The intestinal mucosa is highly expressed with taste receptor proteins, including T1R2 and T1R3 [20]. The Na+/glucose cotransporter SGLT1 is the major route for transport of dietary sugars from the lumen of the intestine into enterocytes. Dietary sugar and artificial sweeteners increased SGLT1 expression in wild-type mice, but not in T1R3 or α-gustducin knockout mice [21]. Activation of sweet taste receptors on enteroendocrine cells led to increased GLP-1 and glucagon-like insulinotropic peptide (GIP) release, which in turn leads to upregulation of SGLT1 expression. Furthermore, there is a significant decrease in transcript levels of T1R2 following jejunal glucose perfusion in mice [22]. This suggests that sweet taste receptors function as gut luminal nutrient sensors which helps to regulate glucose balance and nutrient intake.
3.1. L Cells
Sweet taste receptors are expressed by L cells in the distal small intestine. L cells are distributed throughout the GI tract, with greatest density in the ileum and colon [23]. It has long been known that orally administered glucose triggers a much higher release of insulin compared with intravenous injection of glucose. However, the mechanism was largely unknown until Jang et al. demonstrated that human duodenal L cells express sweet taste receptors that act as glucose sensors in the gut [24]. Activation of L cells by glucose leads to release of hormones, including GLP-1 [25]. GLP-1 leads to increased satiety signals, stimulates insulin release, suppresses glucagon secretion, and slows gastric emptying [26,27]. Glucose-stimulated GLP-1 secretion (GSGS) is severely impaired in T1R3-knockout rodents but not in T1R2-knockout mice [28]. This suggests that T1R3 can mediate GSGS by itself in the absence of the full sweet taste receptor heterodimer. Furthermore, SGLT-1-knockout mice show an 80% reduction in GSGS [29]. These data taken collectively suggest that T1R3 and SGLT1 interact in L cells to produce GLP-1, which stimulates insulin production, regulates glucose absorption, and sends satiety signals to the brain.
3.2. K Cells
K cells in the proximal intestine secrete glucagon-like insulinotropic peptide (GIP) in the presence of glucose. GIP is released rapidly postprandially and leads to release of insulin as well as promotes lipid storage in adipocytes [30]. This process is also SGLT1-dependent but it is not currently known whether this process involves taste receptors.
3.3. Enterochromaffin Cells
Enterochromaffin (EC) cells are distributed throughout the GI tract; the EC cells secrete serotonin (5-HT) to mediate changes in motility and secretion as well as in transduction of visceral stimuli [31]. Sweet taste molecules have been reported in EC cells. Animal studies indicate intestinal EC cells express α-gustducin and T1R [32,33]. T1R3 and T2R have also been identified in human small intestinal EC cells which release 5-HT in response to stimulation with sucralose [34]. This suggests that one role for EC cells is nutrient sensing in the gut with subsequent release of 5-HT leading to a variety of downstream effects.
4. Glucose-Sensing by Gut Endocrine Cells
Glucose in the intestinal lumen leads to the release of several regulatory peptides, including the incretin hormones GIP, GLP-1, and GLP-2 as well as 5-HT [35,36]. Several different mechanisms may be involved in glucose-sensing by gut enteroendocrine cells. Evidence suggests that glucose is metabolized, leading to generation of ATP and the closing of KATP channels in the cell membrane, a process that is similar to insulin release from the pancreatic β cell [37,38].
There is likely an additional mechanism of glucose-sensing in the gut, as GLP-1 is secreted in response to non-metabolizable sugars. As described above, glucose and non-metabolizable sugars are transported via SGLT-1. In addition to serving as glucose co-transporters, SGLT-1 and SGLT-3 may also be involved in glucose-sensing with subsequent release of 5-HT and GLP-1 [39,40,41].
Taste receptors in the gut may also be responsible for glucose-sensing. Elements of the sweet taste transduction pathway, including T1R2, T1R3, and α-gustducin are co-expressed in mouse and human enteroendocrine cells [24,32,42,43]. T1Rs may also play a role in the upregulation of SGLT-1 and GLUT2 in the intestinal epithelium in response to glucose as well as in the regulation of GLP-1 secretion [21,24].
5. Neuroanatomy of Sweet Taste
Upon activation of sweet taste receptors, neural afferents of cranial nerves send gustatory information to the rostral division of the nucleus tractus solitarius (rNTS) of the medulla (Figure 3) [44]. In rodents, fibers then ascend ipsilaterally to the parabrachial nucleus (PBN) [45]. From the PBN, a dorsal pathway projects to the parvicellular part of the ventroposteromedial nucleus of the thalamus (VPMpc, the taste thalamic nucleus) and a ventral pathway to the amygdalar and lateral hypothalamic areas. Thalamic afferents then project to the primary gustatory cortex, which is defined as the VPMpc cortical target located within the insular cortex [46]. In primates and humans, rNTS projections bypass PBN and proceed directly to VPMpc [47].
Imaging studies have indicated that sweet, salty, bitter, and umami tastes activate distinct cortical fields in the mammalian primary gustatory cortex and suggest the existence of a gustotopic map in the brain [48]. A recent study demonstrated that direct activation of the cortical fields associated with sweet and bitter tastes elicits specific behavioral responses in mice using two different tasks [49]. In the first task, mice were placed into a two-chamber arena and a light stimulus was delivered to the relevant cortical field only when the animals entered a specific chamber. Mice expressing channelrhodopsin 2 (ChR2) in the sweet cortical field showed a preference for the chamber associated with light stimulation. Meanwhile, mice expressing ChR2 in the bitter cortical field demonstrated avoidance of that chamber. In the second task, mice were trained to lick from a water bottle on presentation of a cue. During licking, a light stimulus was applied to the relevant cortical field. Stimulation of the bitter cortical field in thirsty mice led to a marked reduction in licking. Conversely, light stimulation of the sweet cortical field led to an increase in licking. These findings demonstrate that activation of a specific taste cortical field can bring about specific behaviors that are characteristic of exposure to that taste.
6. Central Regulation of Food Intake and Energy Balance
Nutrient sensing initially occurs in the GI tract. Signals via vagal afferent neurons are sent directly to sympathetic neurons in hindbrain nuclei. These nuclei then project to forebrain areas such as the hypothalamus [51]. The gut thus sends signals to the rest of the body, including the brain, about current nutritional status by secreting hormones, such as ghrelin, GIP, PYY, CCK, and GLP-1, as well as neurotransmitters, such as 5-HT, that are important regulators of glucose and energy homeostasis [52].
These signals are then processed in different brain nuclei, including the melanocortin system. This system is composed of two peptide-expressing populations of neurons in the arcuate nucleus (ARC) and their downstream targets. One set of ARC neurons express the precursor peptide pro-opiomelanocortin (POMC), which is transformed into α-melanocyte-stimulating hormone and serves as an agonist for melanocortin receptor 4 (MC4R). Activation of POMC neurons results in anorexigenic effects, including decreased food intake and weight loss. The second set of neurons express neuropeptide Y (NPY) and the MC4R antagonist/inverse agonist agouti-related protein (AGRP). Activation of NPY-AGRP neurons results in increased food intake and weight gain [53,54]. Downstream sites for both neurons are located in the hypothalamus, including the paraventricular nucleus (PVN), ventromedial hypothalamus (VMH), and the lateral hypothalamic area [55].
The POMC and NPY-AGRP expressing neurons receive input from many different sources (Figure 4). Insulin and leptin may act as adiposity signals, as plasma levels are directly proportional to the amount of stored fuel in adipose tissue. Furthermore, insulin and leptin receptors are expressed throughout the hypothalamus, including on POMC and NPY-AGRP neurons in the ARC [56,57,58,59].
Sweet taste receptors also play a role in nutrient sensing in the hypothalamus similar to mechanisms used in the periphery. Neurons containing T1R2 and T1R3 have been identified in the CNS, including the hypothalamus. Recent data suggest that the majority of sweet taste receptor activity occurs on non-POMC leptin-responding neurons in the hypothalamus [61].
7. Central Actions of Gut Hormones
7.1. Effect of Leptin
Leptin is an anorexigenic hormone that is primarily produced by adipocytes. Leptin is the primary mediator in the hypothalamus that regulates energy balance and food intake [62]. Leptin acts on a specific obese receptor (Ob-R) which is encoded by the db gene [63]. Ob-R is expressed in several hypothalamic nuclei and leads to increased expression of POMC as well as simultaneous reduction of NPY-AGRP expression [64,65]. Mutations in leptin (ob/ob) or its receptor (db/db) produce mice that are hyperphagic and severely obese [66,67,68].
7.2. Leptin and Sweet Taste in Mice
Leptin displays a sweet suppressive effect in studies with mutant mice containing a point mutation of the db gene (db/db mice) that lack a functional leptin receptor (Ob-Rb) [69]. Chorda tympani nerve responses to various taste stimuli were compared in db/db and lean control mice before and after intraperitoneal (i.p.) injection of recombinant leptin. The chorda tympani (CT) nerve transmits taste information from the anterior two-thirds of the tongue [64]. The db/db mice demonstrated greater CT nerve responses to sweet compounds compared to lean control mice. However, after i.p. injection of leptin, CT nerve responses to sweet substances were significantly suppressed in control mice but not in db/db mice. Other substances, such as NaCl, HCl, and quinine were not affected by leptin administration, which suggests that leptin selectively affects sweet taste sensitivity.
Leptin’s target appears to be on sweet taste receptor cells. Studies using real-time polymerase chain reaction (RT-PCR), in situ hybridization, and immunohistochemistry show that the functional leptin receptor Ob-Rb is expressed on taste bud cells, with approximately 30–40% of T1R3 expressing cells co-expressing Ob-Rb (unpublished data) [64]. Further studies show that application of leptin to isolated taste cells leads to a reduction of cell excitability [69]. This suggests that leptin acting on Ob-Rb may suppress sweet taste sensitivity by decreasing responsiveness of sweet taste cells.
7.3. Leptin and Sweet Taste in Humans
Plasma leptin levels show a diurnal variation in humans, with levels peaking around midnight and lowest around noon to mid-afternoon [70]. A study of 91 non-obese subjects demonstrated a link between plasma leptin levels and sweet taste sensitivity in humans [71]. Recognition thresholds for sweet, salty, sour, bitter, and umami tastes were measured using different concentrations of sucrose, glucose, saccharin Na, NaCl, citric acid, quinine HCl, and monosodium glutamate. The authors demonstrated that recognition thresholds for sweet substances were tightly linked with circulating leptin levels. This was not seen with other taste stimuli.
7.4. Effect of Endocannabinoids
Cannabinoids, such as Cannabis sativa (marijuana), have long been known to have an appetite-stimulating effect. However, endogenous endocannabinoids, including anandamide (AEA) and 2-arachidonoyl glycerol (2-AG), and their specific receptors, cannabinoid receptor type 1 (CB1) and cannabinoid receptor 2 (CB2), were only discovered in the 1980s [72,73]. CB1 receptors, which are located in the hypothalamus as well as peripherally, are likely involved in the orexigenic effects of endocannabinoids [74,75]. Evidence of these effects are demonstrated by injection of endocannabinoids in the hypothalamus which stimulates food intake while CB1 deletion in animal models leads to a lean phenotype and resistance to diet-induced obesity [76,77].
The endocannabinoid system is normally tonically inactive and only becomes transiently activated when needed. Leptin likely plays an important counter regulatory role. Genetically obese mice deficient in leptin (ob/ob) who were given a single i.p. injection of rimonabant, a CB1 receptor antagonist, showed reduced food intake [76]. Subsequent experiments where ob/ob mice were then treated with leptin demonstrated significant decreases in levels of endocannabinoids in the hypothalamus, but not in the cerebellum.
Recently, the relationship between endocannabinoids and leptin was further clarified. Jo et al. demonstrated that neurons containing melanin-concentrating hormone (MCH) in the hypothalamus project to the mesolimbic ventral tegmental area [78]. Thus, the area of the brain controlling appetite is linked to the region devoted to pleasure and reward. These MCH neurons are tonically inhibited by γ-aminobutyric acid (GABA) and receive input from the endocannabinoid system as well as leptin. When these MCH neurons are stimulated, it leads to an increase in intracellular calcium and release of endocannabinoids. This subsequently leads to the activation of CB1 receptors on GABA interneurons, which suppresses GABA release, increases excitability of MCH-containing neurons, and results in increased food intake. Conversely, when leptin receptors on MCH neurons are activated, voltage-gated calcium channels are blocked, suppressing endocannabinoid release, and this leads to an appetite-suppressing effect of leptin.
7.5. Sweet Enhancing Effect of Endocannabinoids
Endocannabinoids also likely enhance taste cell responses to sweeteners. Intraperitoneal administration of endocannabinoids led to a dose-dependent increase in CT glossopharyngeal nerve responses to sweeteners in mice [79]. This was not observed for salty, sour, bitter, or umami compounds or in CB1 knockout mice. These effects were also blocked by administration of AM251, a CB1 receptor antagonist, but not by AM630, a CB2 receptor antagonist. The authors further demonstrated by immunohistochemistry that sweet taste cells expressing T1R3 also express CB1 receptors. These findings suggest that endocannabinoids may enhance sweet taste response in sweet taste cells expressing T1R3.
8. Conclusions
Sweet taste receptors and sweet taste molecules are involved in transduction of sweet taste in taste buds. Furthermore, it is clear that sweet taste pathways are present in the gut and in the CNS, including the appetite center in the hypothalamus. Accumulating data suggest that these pathways act as nutrient sensors in the gut and the brain. They also serve to regulate energy balance, glucose homeostasis, and food intake. Interactions between peripheral and central pathways are carefully regulated with input from peripheral mediators, such as leptin, ghrelin, insulin, GLP-1, and endocannabinoids. Further elucidation of these pathways may provide invaluable insight into the pathogenesis of common diseases, including obesity and type 2 diabetes mellitus.
Acknowledgments
This was work supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants R01-DK048419 (C. Owyang) and P30-DK34933 (C. Owyang).
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Laugerette F., Passilly-Degrace P., Patris B., Niot I., Febbraio M., Montmayeur J.-P., Besnard P. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. J. Clin. Investig. 2005;115:3177–3184. doi: 10.1172/JCI25299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Janssen S., Depoortere I. Nutrient sensing in the gut: New roads to therapeutics? Trends Endocrinol. Metab. 2013;24:92–100. doi: 10.1016/j.tem.2012.11.006. [DOI] [PubMed] [Google Scholar]
- 3.Finger T.E., Danilova V., Barrows J., Bartel D.L., Vigers A.J., Stone L., Hellekant G., Kinnamon S.C. Neuroscience: ATP signalling is crucial for communication from taste buds to gustatory nerves. Science. 2005;310:1495–1499. doi: 10.1126/science.1118435. [DOI] [PubMed] [Google Scholar]
- 4.Bo X., Alavi A., Xiang Z., Oglesby I., Ford A., Burnstock G. Localization of ATP-gated P2X2 and P2X3 receptor immunoreactive nerves in rat taste buds. NeuroReport. 1999;10:1107–1111. doi: 10.1097/00001756-199904060-00037. [DOI] [PubMed] [Google Scholar]
- 5.Yang R., Montoya A., Bond A., Walton J., Kinnamon J.C. Immunocytochemical analysis of P2X2 in rat circumvallate taste buds. BMC Neurosci. 2012;13:51. doi: 10.1186/1471-2202-13-51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Chaudhari N., Roper S.D. The cell biology of taste. J. Cell Biol. 2010;190:285–296. doi: 10.1083/jcb.201003144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nelson G., Hoon M.A., Chandrashekar J., Zhang Y., Ryba N.J.P., Zuker C.S. Mammalian sweet taste receptors. Cell. 2001;106:381–390. doi: 10.1016/S0092-8674(01)00451-2. [DOI] [PubMed] [Google Scholar]
- 8.Li X., Staszewski L., Xu H., Durick K., Zoller M., Adler E. Human receptors for sweet and umami taste. Proc. Natl. Acad. Sci. USA. 2002;99:4692–4696. doi: 10.1073/pnas.072090199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Jiang P., Cui M., Zhao B., Snyder L.A., Benard L.M.J., Osman R., Max M., Margolskee R.F. Identification of the Cyclamate Interaction Site within the Transmembrane Domain of the Human Sweet Taste Receptor Subunit T1R3. J. Biol. Chem. 2005;280:34296–34305. doi: 10.1074/jbc.M505255200. [DOI] [PubMed] [Google Scholar]
- 10.Depoortere I. Taste receptors of the gut: Emerging roles in health and disease. Gut. 2014;63:179–190. doi: 10.1136/gutjnl-2013-305112. [DOI] [PubMed] [Google Scholar]
- 11.Dotson C.D., Geraedts M.C.P., Munger S.D. Peptide regulators of peripheral taste function. Semin. Cell Dev. Biol. 2013;24:232–239. doi: 10.1016/j.semcdb.2013.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kohno D. Sweet taste receptor in the hypothalamus: A potential new player in glucose sensing in the hypothalamus. J. Physiol. Sci. 2017;67:459–465. doi: 10.1007/s12576-017-0535-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lee R.J., Cohen N.A. Bitter and sweet taste receptors in the respiratory epithelium in health and disease. J. Mol. Med. Berl. Ger. 2014;92:1235–1244. doi: 10.1007/s00109-014-1222-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Meyer D., Voigt A., Widmayer P., Borth H., Huebner S., Breit A., Marschall S., Hrabé de Angelis M., Boehm U., Meyerhof W., et al. Expression of Tas1 Taste Receptors in Mammalian Spermatozoa: Functional Role of Tas1r1 in Regulating Basal Ca2+ and cAMP Concentrations in Spermatozoa. PLoS ONE. 2012;7:e32354. doi: 10.1371/journal.pone.0032354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Furness J.B., Rivera L.R., Cho H.-J., Bravo D.M., Callaghan B. The gut as a sensory organ. Nat. Rev. Gastroenterol. Hepatol. 2013;10:729–740. doi: 10.1038/nrgastro.2013.180. [DOI] [PubMed] [Google Scholar]
- 16.Raybould H.E. Nutrient Tasting and Signaling Mechanisms in the Gut. I. Sensing of lipid by the intestinal mucosa. Am. J. Physiol.-Gastrointest. Liver Physiol. 1999;277:G751–G755. doi: 10.1152/ajpgi.1999.277.4.G751. [DOI] [PubMed] [Google Scholar]
- 17.Owyang C., Logsdon C.D. New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology. 2004;127:957–969. doi: 10.1053/j.gastro.2004.05.002. [DOI] [PubMed] [Google Scholar]
- 18.Drucker D.J. The role of gut hormones in glucose homeostasis. J. Clin. Investig. 2007;117:24–32. doi: 10.1172/JCI30076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Strader A.D., Woods S.C. Gastrointestinal hormones and food intake. Gastroenterology. 2005;128:175–191. doi: 10.1053/j.gastro.2004.10.043. [DOI] [PubMed] [Google Scholar]
- 20.Bezençon C., le Coutre J., Damak S. Taste-signaling proteins are coexpressed in solitary intestinal epithelial cells. Chem. Senses. 2007;32:41–49. doi: 10.1093/chemse/bjl034. [DOI] [PubMed] [Google Scholar]
- 21.Margolskee R.F., Dyer J., Kokrashvili Z., Salmon K.S.H., Ilegems E., Daly K., Maillet E.L., Ninomiya Y., Mosinger B., Shirazi-Beechey S.P. T1R3 and gustducin in gut sense sugars to regulate expression of Na+-glucose cotransporter 1. Proc. Natl. Acad. Sci. USA. 2007;104:15075–15080. doi: 10.1073/pnas.0706678104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Young R.L., Sutherland K., Pezos N., Brierley S.M., Horowitz M., Rayner C.K., Blackshaw L.A. Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut. 2009;58:337–346. doi: 10.1136/gut.2008.148932. [DOI] [PubMed] [Google Scholar]
- 23.Young R.L. Sensing via Intestinal Sweet Taste Pathways. Front Neurosci. 2011;5:23. doi: 10.3389/fnins.2011.00023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Jang H.-J., Kokrashvili Z., Theodorakis M.J., Carlson O.D., Kim B.-J., Zhou J., Kim H.H., Xu X., Chan S.L., Juhaszova M., et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc. Natl. Acad. Sci. USA. 2007;104:15069–15074. doi: 10.1073/pnas.0706890104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Gerspach A.C., Steinert R.E., Schönenberger L., Graber-Maier A., Beglinger C. The role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in humans. Am. J. Physiol.-Endocrinol. Metab. 2011;301:E317–E325. doi: 10.1152/ajpendo.00077.2011. [DOI] [PubMed] [Google Scholar]
- 26.Schirra J., Göke B. The physiological role of GLP-1 in human: Incretin, ileal brake or more? Regul. Pept. 2005;128:109–115. doi: 10.1016/j.regpep.2004.06.018. [DOI] [PubMed] [Google Scholar]
- 27.Horowitz M., Nauck M.A. To be or not to be—An incretin or enterogastrone? Gut. 2006;55:148–150. doi: 10.1136/gut.2005.071787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Geraedts M.C.P., Takahashi T., Vigues S., Markwardt M.L., Nkobena A., Cockerham R.E., Hajnal A., Dotson C.D., Rizzo M.A., Munger S.D. Transformation of postingestive glucose responses after deletion of sweet taste receptor subunits or gastric bypass surgery. Am. J. Physiol.-Endocrinol. Metab. 2012;303:E464–E474. doi: 10.1152/ajpendo.00163.2012. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 29.Gorboulev V., Schürmann A., Vallon V., Kipp H., Jaschke A., Klessen D., Friedrich A., Scherneck S., Rieg T., Cunard R., et al. Na(+)-d-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes. 2012;61:187–196. doi: 10.2337/db11-1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131–2157. doi: 10.1053/j.gastro.2007.03.054. [DOI] [PubMed] [Google Scholar]
- 31.Mawe G.M., Hoffman J.M. Serotonin signalling in the gut—Functions, dysfunctions and therapeutic targets. Nat. Rev. Gastroenterol. Hepatol. 2013;10:473–486. doi: 10.1038/nrgastro.2013.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sutherland K., Young R.L., Cooper N.J., Horowitz M., Blackshaw L.A. Phenotypic characterization of taste cells of the mouse small intestine. Am. J. Physiol.-Gastrointest. Liver Physiol. 2007;292:G1420–G1428. doi: 10.1152/ajpgi.00504.2006. [DOI] [PubMed] [Google Scholar]
- 33.Moran A.W., Al-Rammahi M.A., Arora D.K., Batchelor D.J., Coulter E.A., Ionescu C., Bravo D., Shirazi-Beechey S.P. Expression of Na+/glucose co-transporter 1 (SGLT1) in the intestine of piglets weaned to different concentrations of dietary carbohydrate. Br. J. Nutr. 2010;104:647–655. doi: 10.1017/S0007114510000954. [DOI] [PubMed] [Google Scholar]
- 34.Kidd M., Modlin I.M., Gustafsson B.I., Drozdov I., Hauso O., Pfragner R. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am. J. Physiol. Gastrointest. Liver Physiol. 2008;295:G260–G272. doi: 10.1152/ajpgi.00056.2008. [DOI] [PubMed] [Google Scholar]
- 35.Dubé P.E., Brubaker P.L. Frontiers in glucagon-like peptide-2: Multiple actions, multiple mediators. Am. J. Physiol.-Endocrinol. Metab. 2007;293:E460–E465. doi: 10.1152/ajpendo.00149.2007. [DOI] [PubMed] [Google Scholar]
- 36.Raybould H.E. Sensing of glucose in the gastrointestinal tract. Auton. Neurosci. Basic. Clin. 2007;133:86–90. doi: 10.1016/j.autneu.2007.01.006. [DOI] [PubMed] [Google Scholar]
- 37.Reimann F., Gribble F.M. Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells. Diabetes. 2002;51:2757–2763. doi: 10.2337/diabetes.51.9.2757. [DOI] [PubMed] [Google Scholar]
- 38.Schuit F.C., Huypens P., Heimberg H., Pipeleers D.G. Glucose Sensing in Pancreatic β-Cells. Diabetes. 2001;50:1–11. doi: 10.2337/diabetes.50.1.1. [DOI] [PubMed] [Google Scholar]
- 39.Gribble F.M., Williams L., Simpson A.K., Reimann F. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes. 2003;52:1147–1154. doi: 10.2337/diabetes.52.5.1147. [DOI] [PubMed] [Google Scholar]
- 40.Freeman S.L., Bohan D., Darcel N., Raybould H.E. Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am. J. Physiol.-Gastrointest. Liver Physiol. 2006;291:G439–G445. doi: 10.1152/ajpgi.00079.2006. [DOI] [PubMed] [Google Scholar]
- 41.Raybould H.E. Gut chemosensing: Interactions between gut endocrine cells and visceral afferents. Auton. Neurosci. 2010;153:41–46. doi: 10.1016/j.autneu.2009.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Dyer J., Daly K., Salmon K.S.H., Arora D.K., Kokrashvili Z., Margolskee R.F., Shirazi-Beechey S.P. Intestinal glucose sensing and regulation of intestinal glucose absorption. Biochem. Soc. Trans. 2007;35:1191–1194. doi: 10.1042/BST0351191. [DOI] [PubMed] [Google Scholar]
- 43.Rozengurt N., Wu S.V., Chen M.C., Huang C., Sternini C., Rozengurt E. Colocalization of the α-subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am. J. Physiol.-Gastrointest. Liver Physiol. 2006;291:G792–G802. doi: 10.1152/ajpgi.00074.2006. [DOI] [PubMed] [Google Scholar]
- 44.Hamilton R.B., Norgren R. Central projections of gustatory nerves in the rat. J. Comp. Neurol. 1984;222:560–577. doi: 10.1002/cne.902220408. [DOI] [PubMed] [Google Scholar]
- 45.Norgren R., Leonard C.M. Taste Pathways in Rat Brainstem. Science. 1971;173:1136–1139. doi: 10.1126/science.173.4002.1136. [DOI] [PubMed] [Google Scholar]
- 46.Fernstrom J.D., Munger S.D., Sclafani A., de Araujo I.E., Roberts A., Molinary S. Mechanisms for sweetness. J. Nutr. 2012;142:1134S–1141S. doi: 10.3945/jn.111.149567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Scott T.R., Small D.M. The Role of the Parabrachial Nucleus in Taste Processing and Feeding. Ann. NY Acad. Sci. 2009;1170:372–377. doi: 10.1111/j.1749-6632.2009.03906.x. [DOI] [PubMed] [Google Scholar]
- 48.Chen X., Gabitto M., Peng Y., Ryba N.J.P., Zuker C.S. A gustotopic map of taste qualities in the mammalian brain. Science. 2011;333:1262–1266. doi: 10.1126/science.1204076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Peng Y., Gillis-Smith S., Jin H., Tränkner D., Ryba N.J.P., Zuker C.S. Sweet and bitter taste in the brain of awake behaving animals. Nature. 2015;527:512–515. doi: 10.1038/nature15763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.San Gabriel A.M. Taste receptors in the gastrointestinal system. Flavour. 2015;4:14. doi: 10.1186/2044-7248-4-14. [DOI] [Google Scholar]
- 51.DiRocco R.J., Grill H.J. The forebrain is not essential for sympathoadrenal hyperglycemic response to glucoprivation. Science. 1979;204:1112–1114. doi: 10.1126/science.451558. [DOI] [PubMed] [Google Scholar]
- 52.Perry B., Wang Y. Appetite regulation and weight control: The role of gut hormones. Nutr. Diabetes. 2012;2:e26. doi: 10.1038/nutd.2011.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Grayson B.E., Seeley R.J., Sandoval D.A. Wired on sugar: The role of the CNS in the regulation of glucose homeostasis. Nat. Rev. Neurosci. 2013;14:24–37. doi: 10.1038/nrn3409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hahn T.M., Breininger J.F., Baskin D.G., Schwartz M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat. Neurosci. 1998;1:271–272. doi: 10.1038/1082. [DOI] [PubMed] [Google Scholar]
- 55.Cone R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 2005;8:571–578. doi: 10.1038/nn1455. [DOI] [PubMed] [Google Scholar]
- 56.Brüning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Müller-Wieland D., Kahn C.R. Role of Brain Insulin Receptor in Control of Body Weight and Reproduction. Science. 2000;289:2122–2125. doi: 10.1126/science.289.5487.2122. [DOI] [PubMed] [Google Scholar]
- 57.Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269:543–546. doi: 10.1126/science.7624777. [DOI] [PubMed] [Google Scholar]
- 58.Baskin D.G., Breininger J.F., Schwartz M.W. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes. 1999;48:828–833. doi: 10.2337/diabetes.48.4.828. [DOI] [PubMed] [Google Scholar]
- 59.Baskin D.G., Figlewicz Lattemann D., Seeley R.J., Woods S.C., Porte D., Jr., Schwartz M.W. Insulin and leptin: Dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res. 1999;848:114–123. doi: 10.1016/S0006-8993(99)01974-5. [DOI] [PubMed] [Google Scholar]
- 60.Williams K.W., Elmquist J.K. From neuroanatomy to behavior: Central integration of peripheral signals regulating feeding behavior. Nat. Neurosci. 2012;15:1350–1355. doi: 10.1038/nn.3217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Kohno D., Koike M., Ninomiya Y., Kojima I., Kitamura T., Yada T. Sweet Taste Receptor Serves to Activate Glucose-and Leptin-Responsive Neurons in the Hypothalamic Arcuate Nucleus and Participates in Glucose Responsiveness. Front Neurosci. 2016;10:502. doi: 10.3389/fnins.2016.00502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763–770. doi: 10.1038/27376. [DOI] [PubMed] [Google Scholar]
- 63.Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–432. doi: 10.1038/372425a0. [DOI] [PubMed] [Google Scholar]
- 64.Yoshida R., Niki M., Jyotaki M., Sanematsu K., Shigemura N., Ninomiya Y. Modulation of sweet responses of taste receptor cells. Semin. Cell Dev. Biol. 2013;24:226–231. doi: 10.1016/j.semcdb.2012.08.004. [DOI] [PubMed] [Google Scholar]
- 65.Woods S.C., Seeley R.J., Porte D., Schwartz M.W. Signals That Regulate Food Intake and Energy Homeostasis. Science. 1998;280:1378–1383. doi: 10.1126/science.280.5368.1378. [DOI] [PubMed] [Google Scholar]
- 66.Chen H., Charlat O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpepper J., Moore K.J., Breitbart R.E., et al. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996;84:491–495. doi: 10.1016/S0092-8674(00)81294-5. [DOI] [PubMed] [Google Scholar]
- 67.Lee G.H., Proenca R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 1996;379:632–635. doi: 10.1038/379632a0. [DOI] [PubMed] [Google Scholar]
- 68.Berglund E.D., Vianna C.R., Donato J., Kim M.H., Chuang J.-C., Lee C.E., Friedman J.M. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J. Clin. Investig. 2012;122:1000–1009. doi: 10.1172/JCI59816. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Kawai K., Sugimoto K., Nakashima K., Miura H., Ninomiya Y. Leptin as a modulator of sweet taste sensitivities in mice. Proc. Natl. Acad. Sci. USA. 2000;97:11044–11049. doi: 10.1073/pnas.190066697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Sinha M.K., Sturis J., Ohannesian J., Magosin S., Stephens T., Heiman M.L., Polonsky K.S., Caro J.F. Ultradian oscillations of leptin secretion in humans. Biochem. Biophys. Res. Commun. 1996;228:733–738. doi: 10.1006/bbrc.1996.1724. [DOI] [PubMed] [Google Scholar]
- 71.Nakamura Y., Sanematsu K., Ohta R., Shirosaki S., Koyano K., Nonaka K., Shigemura N., Ninomiya Y. Diurnal variation of human sweet taste recognition thresholds is correlated with plasma leptin levels. Diabetes. 2008;57:2661–2665. doi: 10.2337/db07-1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561–564. doi: 10.1038/346561a0. [DOI] [PubMed] [Google Scholar]
- 73.Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61–65. doi: 10.1038/365061a0. [DOI] [PubMed] [Google Scholar]
- 74.Cota D., Marsicano G., Tschöp M., Grübler Y., Flachskamm C., Schubert M., Auer D., Yassouridis A., Thöne-Reineke C., Ortmann S., et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Investig. 2003;112:423–431. doi: 10.1172/JCI17725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Jamshidi N., Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br. J. Pharmacol. 2001;134:1151–1154. doi: 10.1038/sj.bjp.0704379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Di Marzo V., Goparaju S.K., Wang L., Liu J., Bátkai S., Járai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 2001;410:822–825. doi: 10.1038/35071088. [DOI] [PubMed] [Google Scholar]
- 77.Ravinet Trillou C., Delgorge C., Menet C., Arnone M., Soubrié P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. 2004;28:640–648. doi: 10.1038/sj.ijo.0802583. [DOI] [PubMed] [Google Scholar]
- 78.Jo Y.-H., Chen Y.-J.J., Chua J., Talmage D.A., Role L.W. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron. 2005;48:1055–1066. doi: 10.1016/j.neuron.2005.10.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Yoshida R., Ohkuri T., Jyotaki M., Yasuo T., Horio N., Yasumatsu K., Sanematsu K., Shigemura N., Yamamoto T., Margolskee R.F., et al. Endocannabinoids selectively enhance sweet taste. Proc. Natl. Acad. Sci. USA. 2010;107:935–939. doi: 10.1073/pnas.0912048107. [DOI] [PMC free article] [PubMed] [Google Scholar]